Piper Sandler analyst Brent Bracelin reiterates Adobe (NASDAQ:ADBE) with a Overweight and maintains $415 price target.
Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate
Arvinas Inc (NASDAQ: ARVN) and Pfizer Inc (NYSE: PFE) released clinical data for vepdegestrant (ARV-471) in combination with